# Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19

> **NCT04746066** · — · RECRUITING · sponsor: **Società Italiana Talassemie ed Emoglobinopatie** · enrollment: 10000 (estimated)

## Conditions studied

- Haemoglobinopathies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04746066
- **Lead sponsor:** Società Italiana Talassemie ed Emoglobinopatie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-31
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04746066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04746066, "Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04746066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*